(Q59157377)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20018366%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

title

Large trials confirm immunogenicity of H1N1 vaccines (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20018366%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

language of work or name

English

0 references

publication date

15 December 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20018366%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20018366%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

375

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20018366%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

9708

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20018366%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

6-9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20018366%20AND%20SRC:MED&resulttype=core&format=json

Pandemic H1N1 influenza lessons from the southern hemisphere

15 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962132-2

7 January 2021

Response to a monovalent 2009 influenza A (H1N1) vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962132-2

7 January 2021

Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962132-2

7 January 2021

Interpretation of responses and protective levels of antibody against attenuated influenza A viruses using single radial haemolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962132-2

7 January 2021

The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962132-2

7 January 2021

Reproducibility of serologic assays for influenza virus A (H5N1).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962132-2

7 January 2021

On the relationship between mean antibody level, seroprotection and clinical protection from influenza.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962132-2

7 January 2021

Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962132-2

7 January 2021

Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962132-2

7 January 2021

Critical care services and 2009 H1N1 influenza in Australia and New Zealand.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962132-2

7 January 2021